(Q42814993)

7 November 2017

Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro (English)

1 reference

7 November 2017

1 reference

D F Smee

1

1 reference

PubMed ID

12018677

7 November 2017

M Bray

series ordinal

2

1 reference

PubMed ID

12018677

7 November 2017

J W Huggins

series ordinal

3

1 reference

7 November 2017

1 November 2001

1 reference

Antiviral Chemistry & Chemotherapy

7 November 2017

1 reference

7 November 2017

12

1 reference

7 November 2017

6

1 reference

7 November 2017

327-335

1 reference

Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests

7 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Field trials of methisazone as a prophylactic agent against smallpox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Re-emergence of monkeypox in Africa: a review of the past six years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

The relationship between the metabolism of ribavirin and its proposed mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Measurement of cell numbers in microtiter culture plates using the fluorescent dye Hoechst 33258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Mechanism of action of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200602

10.1177/095632020101200602

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference

PubMed ID

12018677